Jeffrey A Meckler Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey A Meckler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey A Meckler. Jeffrey A Meckler is Director in QLT INC/BC ($QLTI) and in Cocrystal Pharma, Inc. ($BZNE) and CHIEF EXECUTIVE OFFICER in Cocrystal Pharma, Inc. ($BZNE) and Director in Retrophin, Inc. ($RTRX) and Chief Executive Officer in Intec Pharma Ltd. ($NTEC).
Latest Insider Trading Transactions of Jeffrey A Meckler
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, COCP, NTEC, NVLN, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Option Exercise | A | 18.27 | 9,000 | 164,430 | 9,000 | |
| May 18 2021 | RTRX | Travere Therapeuti ... | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 67,000 | 64 K to 67 K (+4.69 %) |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Option Exercise | A | 0.31 | 300,000 | 92,250 | 300,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 3,000 | 0 | 64,000 | 61 K to 64 K (+4.92 %) |
| Aug 29 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.68 | 20,000 | 13,620 | 196,761 | 176.8 K to 196.8 K (+11.31 %) |
| Aug 27 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.46 | 100,000 | 45,700 | 176,761 | 76.8 K to 176.8 K (+130.27 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 61,000 | 59 K to 61 K (+3.39 %) |
| Apr 05 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Option Exercise | A | 7.64 | 125,000 | 955,000 | 125,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 26.52 | 10,000 | 265,200 | 10,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,500 | 0 | 59,000 | 56.5 K to 59 K (+4.42 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,500 | 0 | 56,500 | 54 K to 56.5 K (+4.63 %) |
| Jun 21 2016 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | A | 0.00 | 6,400 | 0 | 28,400 | |
| Jun 21 2016 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | A | 1.43 | 50,000 | 71,500 | 50,000 | |
| May 19 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 16.33 | 8,000 | 130,640 | 8,000 | |
| May 19 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 54,000 | 52 K to 54 K (+3.85 %) |
| Mar 07 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Buy | P | 15.31 | 5,000 | 76,565 | 52,000 | 47 K to 52 K (+10.64 %) |
| Mar 03 2016 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Buy | P | 14.45 | 10,000 | 144,500 | 47,000 | 37 K to 47 K (+27.03 %) |
| Mar 17 2016 | BZNE | Cocrystal Pharma, ... | Meckler Jeffrey A | CHIEF EXECUTIVE OFF ... | Buy | P | 0.51 | 294,118 | 150,000 | 657,161 | 363 K to 657.2 K (+81.01 %) |
| Dec 28 2015 | BZNE | Cocrystal Pharma, ... | Meckler Jeffrey A | CHIEF EXECUTIVE OFF ... | Buy | P | 0.58 | 100,000 | 57,870 | 363,043 | 263 K to 363 K (+38.02 %) |
| Oct 02 2015 | BZNE | Cocrystal Pharma, ... | Meckler Jeffrey A | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.70 | 16,000,000 | 11,200,000 | 16,000,000 | |
| Jul 01 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | M | 3.30 | 12,500 | 41,250 | 0 | |
| Jul 01 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | M | 3.67 | 12,500 | 45,875 | 0 | |
| Jul 01 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Buy | M | 3.30 | 12,500 | 41,250 | 107,000 | 94.5 K to 107 K (+13.23 %) |
| Jul 01 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Buy | M | 3.67 | 12,500 | 45,875 | 94,500 | 82 K to 94.5 K (+15.24 %) |
| Jun 10 2015 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 32.59 | 8,000 | 260,720 | 8,000 | |
| Jun 10 2015 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 37,000 | 35 K to 37 K (+5.71 %) |
| Jun 09 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
| Jun 09 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Option Exercise | M | 0.00 | 4,000 | 0 | 0 | |
| Jun 09 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Buy | M | 0.00 | 6,000 | 0 | 82,000 | 76 K to 82 K (+7.89 %) |
| Jun 09 2015 | QLTI | QLT INC/BC | Meckler Jeffrey A | Director | Buy | M | 0.00 | 4,000 | 0 | 76,000 | 72 K to 76 K (+5.56 %) |
| Mar 27 2015 | BZNE | Cocrystal Pharma, ... | Meckler Jeffrey A | Buy | P | 0.92 | 163,043 | 150,000 | 263,043 | 100 K to 263 K (+163.04 %) | |
| Mar 25 2015 | BZNE | Cocrystal Pharma, ... | Meckler Jeffrey A | Option Exercise | A | 1.02 | 1,750,000 | 1,776,250 | 1,750,000 |
Page: 1